5 Kohlenhydrate

Glukose - Fruktose - Nicht-Eiweiß-Kalorien - Hyperglykämie - Insulin

glucose - fructose - non-protein-calories - hyperglycaemia - insulin

Literatur

• 1 Elwyn D H, Gump F E, Lles M, Long C L, Kinney J M. Protein and energy sparing of glucose added in hypocaloric amounts to peripheral infusions of amino acids.  Metabolism. 1978;  27 325-331
• 2 Humberstone D A, Koea J, Shaw J H. Relative importance of amino acid infusion as a means of sparing protein in surgical patients.  JPEN J Parenter Enteral Nutr. 1989;  13 223-227
• 3 Young G A, Hill G L. A controlled study of protein-sparing therapy after excision of the rectum: effects of intravenous amino acids and hyperalimentation on body composition and plasma amino acids.  Ann Surg. 1980;  192 183-191
• 4 Shaw J H, Holdaway C M. Protein-sparing effect of substrate infusion in surgical patients is governed by the clinical state, and not by the individual substrate infused.  JPEN J Parenter Enteral Nutr. 1988;  12 433-440
• 5 Long III J M, Wilmore D W, Mason Jr A D, Pruitt Jr B A. Effect of carbohydrate and fat intake on nitrogen excretion during total intravenous feeding.  Ann Surg. 1977;  185 417-422
• 6 Tappy L, Schwarz J M, Schneiter P. et al . Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients.  Crit Care Med. 1998;  26 860-867
• 7 Paluzzi M, Meguid M M. A prospective randomized study of the optimal source of nonprotein calories in total parenteral nutrition.  Surgery. 1987;  102 711-717
• 8 Baker J P, Detsky A S, Stewart S, Whitwell J, Marliss E B, Jeejeebhoy K N. Randomized trial of total parenteral nutrition in critically ill patients: metabolic effects of varying glucose-lipid ratios as the energy source.  Gastroenterology. 1984;  87 53-59
• 9 Macfie J, Smith R C, Hill G L. Glucose or fat as a nonprotein energy source? A controlled clinical trial in gastroenterological patients requiring intravenous nutrition.  Gastroenterology. 1981;  80 103-107
• 10 Chalain T M de, Michell W L, O'Keefe S J, Ogden J M. The effect of fuel source on amino acid metabolism in critically ill patients.  J Surg Res. 1992;  52 167-176
• 11 Lobo D N, Bostock K A, Neal K R, Perkins A C, Rowlands B J, Allison S P. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial.  Lancet. 2002;  359 1812-1818
• 12 Leutenegger A F, Goschke H, Stutz K. et al . Comparison between glucose and a combination of glucose, fructose, and xylitol as carbohydrates for total parenteral nutrition of surgical intensive care patients.  Am J Surg. 1977;  133 199-205
• 13 Behrendt W, Raumanns J, Hanse J, Giani G. Glucose, fructose, and xylitol in postoperative hypocaloric parenteral nutrition.  Infusionstherapie. 1988;  15 170-175
• 14 Ladefoged K, Berthelsen P, Brockner-Nielsen J, Jarnum S, Larsen V. Fructose, xylitol and glucose in total parenteral nutrition.  Intensive Care Med. 1982;  8 19-23
• 15 Valero M A, Leon-Sanz M, Escobar I, Gomis P, Camara A de la, Moreno J M. Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients.  Eur J Clin Nutr. 2001;  55 1111-1116
• 16 Keller U. The sugar substitutes fructose and sorbite: an unnecessary risk in parenteral nutrition.  Schweiz Med Wochenschr. 1989;  119 101-106
• 17 Yamamoto T. Metabolic response to glucose overload in surgical stress: energy disposal in brown adipose tissue.  Surg Today. 1996;  26 151-157
• 18 Napolitano L M. Parenteral nutrition in trauma patients: glucose-based, lipid-based, or none?.  Crit Care Med. 1998;  26 813-814
• 19 Mizock B A. Blood glucose management during critical illness.  Rev Endocr Metab Disord. 2003;  4 187-194
• 20 Al Jaouni R, Schneider S M, Rampal P, Hebuterne X. Effect of age on substrate oxidation during total parenteral nutrition.  Nutrition. 2002;  18 20-25
• 21 Berghe G Van den, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
• 22 Berghe G Van den, Wouters P J, Bouillon R. et al . Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.  Crit Care Med. 2003;  31 359-366
• 23 Mesotten D, Berghe G Van den. Clinical potential of insulin therapy in critically ill patients.  Drugs. 2003;  63 625-636
• 24 Finney S J, Zekveld C, Elia A, Evans T W. Glucose control and mortality in critically ill patients.  JAMA. 2003;  290 2041-2047
• 25 Krinsley J S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.  Mayo Clin Proc. 2003;  78 1471-1478
• 26 Berghe G Van den, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
• 27 Baird T A, Parsons M W, Phanh T. et al . Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.  Stroke. 2003;  34 2208-2214
• 28 Bruno A, Biller J, Adams Jr H P. et al . Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.  Neurology. 1999;  52 280-284
• 29 Demchuk A M, Morgenstern L B, Krieger D W. et al . Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.  Stroke. 1999;  30 34-39
• 30 Bolk J, Ploeg T van der, Cornel J H, Arnold A E, Sepers J, Umans V A. Impaired glucose metabolism predicts mortality after a myocardial infarction.  Int J Cardiol. 2001;  79 207-214
• 31 Stranders I, Diamant M, Gelder R E van. et al . Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.  Arch Intern Med. 2004;  164 982-988
• 32 Capes S E, Hunt D, Malmberg K, Pathak P, Gerstein H C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.  Stroke. 2001;  32 2426-2432